dc.contributor.author | Hacisalihoglu, U. P. | |
dc.contributor.author | Dogan, M. A. | |
dc.date.accessioned | 2021-12-21T08:45:59Z | |
dc.date.available | 2021-12-21T08:45:59Z | |
dc.identifier.issn | 1052-0295 | |
dc.identifier.issn | 1473-7760 | |
dc.identifier.uri | https://doi.org/10.1080/10520295.2021.1973102 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1855 | |
dc.description.abstract | Breast cancer treatment is tailored to molecular subtypes, which are classified by cell type and by presence of estrogen and progesterone receptors, HER2 overexpression and Ki-67 proliferation index. In routine pathological practice, these markers are det | |
dc.language.iso | English | |
dc.publisher | Taylor & Francıs Ltd | |
dc.title | Expression of estrogen and progesterone receptors, HER2 protein and Ki-67 proliferation index in breast carcinoma in both tumor tissue and tissue microarray | |
dc.type | Article; Early Access | |
dc.relation.journal | Bıotechnıc & Hıstochemıstry | |
dc.identifier.doi | 10.1080/10520295.2021.1973102 | |